Wenjie Zhai

机构：Zhengzhou University · ORCID：0000-0002-0707-5422

发表论文 48 篇 · 总被引 1927 次 · h-index 24

代表论文

• An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy (2021 · Journal of Controlled Release · 被引 93)
• Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy (2023 · Journal for ImmunoTherapy of Cancer · 被引 72)
• Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway (2022 · Journal of Experimental & Clinical Cancer Research · 被引 54)
• A Three‐In‐One Assembled Nanoparticle Containing Peptide–Radio‐Sensitizer Conjugate and TLR7/8 Agonist Can Initiate the Cancer‐Immunity Cycle to Trigger Antitumor Immune Response (2022 · Small · 被引 39)
• A PD-L1 and VEGFR2 dual targeted peptide and its combination with irradiation for cancer immunotherapy (2022 · Pharmacological Research · 被引 37)
• Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming (2022 · Cell Death and Disease · 被引 34)